Market Challenges And Opportunities

Medical Automation Market Drivers:

Implementation of automated devices has reduced the task time and labor efforts as machine perform tasks in better manner than the human and has higher consistency for care activities, such as patient’s routine immunoassay analysis, pre/post analytical workflow monitoring, which significantly reduces cost and complications.

Several hospitals are utilizing automated technologies for recording and organizing patient information, contributing to the market growth. For instance, according to the Intuitive Surgical, Inc., surgical procedures perform by using da Vinci systems (Intuitive surgical company’s products) in various hospitals globally, around 877 000 surgical procedures have been performed by this product in 2017, compared with 753 000 procedures in 2016, an increase of 16%. Moreover, the company expects total da Vinci procedures to grow around 11% to 15% in 2018. Thus, automated machines improve clinical outcomes that help patients return to active and productive life more quickly. However, high cost of the automation equipment and lack of skilled professionals majorly in emerging economies are the key restraining factors for market growth.

Robotically assisted surgeries are used to aid in surgical procedures to overcome the limitations of pre-existing minimal invasive surgical procedures to enhance capabilities of the surgeons, which include gynecological, cardiac, neurological, and orthopedic. Robotic assisted surgeries are carried out with precision, miniaturization, smaller incisions such as decreased blood loss, less pain, and quick healing time, which significantly reduces the hospital stay and blood transfusion. According to health research funding organization, the rate of robotic surgeries is increasing by 25% annually and in 2012, approximately 400,000 robotic surgeries were performed across U.S.

Market is also expected to witness significant growth as government investments are increasing, policies continue to improving, and collaboration among market players. For instance, in 2018, Orgenesis Inc. collaborated with the Atvio Biotech Ltd., an innovator of enhanced bioprocessing solutions for the development and distribution of advanced automated culturing system for manufacturing autologous cell therapies. Furthermore, major investments on healthcare research by various manufacturers is contributing to the market growth. For instance, in 2017, Siemens AG successfully installed India’s first fully automated Aptio automation track with multidiscipline modalities at the Aspira Pathlab and Diagnostic Ltd, Mumbai.